Covid-19 roundup: FDA has finally posted discussion items for tomorrow's adcomm; AstraZeneca could soon resume US vaccine trials
It may have come a day late, but the FDA has finally posted the discussion items that its outside experts will review during tomorrow’s adcomm …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
